Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Stake Boosted by Profund Advisors LLC

Profund Advisors LLC boosted its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 9.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 74,363 shares of the pharmacy operator’s stock after buying an additional 6,474 shares during the period. Profund Advisors LLC’s holdings in Walgreens Boots Alliance were worth $2,966,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in WBA. Johnson Midwest Financial LLC acquired a new stake in shares of Walgreens Boots Alliance in the fourth quarter valued at $26,000. McIlrath & Eck LLC acquired a new stake in Walgreens Boots Alliance in the 3rd quarter valued at about $29,000. Holloway Wealth Management LLC acquired a new stake in Walgreens Boots Alliance in the 3rd quarter valued at about $32,000. McCarthy Asset Management Inc. bought a new position in shares of Walgreens Boots Alliance during the 4th quarter valued at about $32,000. Finally, Hexagon Capital Partners LLC grew its stake in shares of Walgreens Boots Alliance by 6,641.7% in the 4th quarter. Hexagon Capital Partners LLC now owns 809 shares of the pharmacy operator’s stock worth $32,000 after purchasing an additional 797 shares during the last quarter. Hedge funds and other institutional investors own 55.96% of the company’s stock.

Shares of WBA opened at $48.86 on Tuesday. The company has a market capitalization of $42.22 billion, a PE ratio of 97.72, a PEG ratio of 1.52 and a beta of 0.44. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.32 and a current ratio of 0.67. The company’s 50 day moving average price is $48.43 and its 200 day moving average price is $41.00. Walgreens Boots Alliance, Inc. has a 52 week low of $33.36 and a 52 week high of $55.49.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Wednesday, January 6th. The pharmacy operator reported $1.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.03 by $0.19. Walgreens Boots Alliance had a net margin of 0.33% and a return on equity of 18.33%. The company had revenue of $36.31 billion during the quarter, compared to the consensus estimate of $35.01 billion. During the same quarter in the prior year, the firm earned $1.37 EPS. The company’s revenue was up 5.7% compared to the same quarter last year. On average, equities analysts forecast that Walgreens Boots Alliance, Inc. will post 4.84 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 12th. Investors of record on Friday, February 19th will be given a dividend of $0.4675 per share. The ex-dividend date of this dividend is Thursday, February 18th. This represents a $1.87 dividend on an annualized basis and a yield of 3.83%. Walgreens Boots Alliance’s payout ratio is 39.45%.

Several analysts recently commented on the stock. Guggenheim raised shares of Walgreens Boots Alliance from a “neutral” rating to a “buy” rating and set a $55.00 target price for the company in a research note on Monday, January 11th. Truist Financial raised their price objective on Walgreens Boots Alliance from $40.00 to $44.00 in a research note on Tuesday, January 5th. TheStreet cut Walgreens Boots Alliance from a “b-” rating to a “c” rating in a report on Thursday, January 7th. Robert W. Baird raised Walgreens Boots Alliance from a “neutral” rating to an “outperform” rating and boosted their target price for the stock from $41.00 to $55.00 in a research report on Monday, January 11th. Finally, Zacks Investment Research upgraded Walgreens Boots Alliance from a “sell” rating to a “hold” rating and set a $38.00 price target for the company in a research report on Monday, January 11th. Two equities research analysts have rated the stock with a sell rating, fourteen have issued a hold rating and two have assigned a buy rating to the company. The stock has an average rating of “Hold” and a consensus target price of $44.50.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and beauty retail company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.

Recommended Story: Float

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.